Impact of anti-osteoporotic treatments on hyperlipidemia risk in osteoporosis patients: evidence from a population-based retrospective cohort study
Our findings suggest a significant association between osteoporosis and increased risk of hyperlipidemia in Asian populations, and highlight the potential protective role of AOTs against hyperlipidemia. These insights could inform clinical strategies to manage patients with osteoporosis and mitigate their risk of CVD.
Authors
- Fuu‐Jen Tsai (ORCID: https://orcid.org/0000-0002-1373-245X)
- Wookjin Lee (ORCID: https://orcid.org/0000-0002-1907-1111)
- Yun-Ping Lim (ORCID: https://orcid.org/0000-0001-9312-048X)
- Wendy Wong (ORCID: https://orcid.org/0000-0001-8731-0498)
- Yi‐Jen Fang
- Ni Tien
- Chi‐Hua Chen (ORCID: https://orcid.org/0000-0002-3547-7584)
- Cheng‐Li Lin (ORCID: https://orcid.org/0000-0002-7315-7709)
- Bang‐Jau You
- Hui‐Hsia Hsieh (ORCID: https://orcid.org/0000-0002-0874-195X)
Institutions
- Asia University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taipei Tzu Chi Hospital (TW)
- Chang Bing Show Chwan Memorial Hospital (TW)
- China Medical University Hospital (TW)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1186/s40001-025-03130-0
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Medical University Hospital
- Buddhist Tzu Chi Medical Foundation
- China Medical University
- National Science and Technology Council
- Division of Materials Research